Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Drug Deliv Transl Res. 2018 Aug;8(4):964–984. doi: 10.1007/s13346-017-0419-y

Table 1B.

Design of experiment to assess effects of exogenous DOX dose on elastic matrix neoassembly and proteolytic activity in cytokine (TNF-α and IL-1β; 10 ng/ml each)-injured EaRASMC cultures. Outcomes were measured in harvested cell layers at 21 days post-seeding.

Case Cell Amount/ Type/# Cultures Day 7 Serum Starve: 3 h
Treatment: 30 min
Treatment Day 8 and Day 14
(Till Harvest on Day 21)
1% FBS 10% FBS
Healthy Cell Controls 30K, RASMC, n=3
Treatment Controls 30K, EaRASMC, n=3 Cytokines Cytokines
DOX (0.1 μg/mL) 30K, EaRASMC, n=3 DOX, Cytokines DOX, Cytokines
DOX (1 μg/mL) 30K, EaRASMC, n=3 DOX, Cytokines DOX, Cytokines
DOX (10 μg/mL) 30K, EaRASMC, n=3 DOX, Cytokines DOX, Cytokines
DOX (20 μg/mL) 30K, EaRASMC, n=3 DOX, Cytokines DOX, Cytokines
DOX (50 μg/mL) 30K, EaRASMC, n=3 DOX, Cytokines DOX, Cytokines